Federal Supply Schedule 36F79721D0215
Award Date
8/15/21
Last Date to Order
8/14/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Neurelis Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA), is for the procurement of pharmaceuticals, drugs, and hematology-related products. The contract holder is Neos Therapeutics, LP, a for-profit organization. The contract has a ceiling value of $450,000.00 and a period of performance ending on July 31, 2026. As a Federal Supply Schedule contract, it is a multiple-award vehicle that allows federal agencies to purchase the specified products and services....
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12, a civilian agency, to Neurotech Pharmaceuticals, Inc. The contract is for the delivery of drugs, pharmaceuticals, and hematology related products under Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a period of performance from July 4, 2025 to December 31, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows federal agencies to procure the...
The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to provide drugs, pharmaceuticals, and hematology-related products to VHA facilities. The prime contractor is Nabriva Therapeutics US Inc., a for-profit organization. The contract has a potential value of $225,000 and a period of performance through October 15, 2023. No set-asides were used in the...
This Federal Supply Schedule (FSS) contract is awarded by the Department of Veterans Affairs (VA) to Paratek Pharmaceuticals, Inc. The contract, identified as 36F79719D0194, is for pharmaceutical and drug products under the FSS-61-IB schedule. The contract has a period of performance from July 15, 2019 to February 1, 2026, with a ceiling value of $225,000.00. The contract is intended to provide the VA with a variety of pharmaceutical and drug products, including those related to hematology. As a...
The Federal Supply Schedule contract awarded to Supernus Pharmaceuticals, Inc. by Veterans Integrated Service Network 12 is a five-year, $132.6 million agreement to provide drugs, pharmaceuticals, and hematology-related products to the Department of Veterans Affairs. As a multiple award schedule under Federal Supply Schedule 65 IB, this contract enables VA medical facilities to directly order from Supernus's pre-approved catalog of offerings. The contract aims to efficiently deliver...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for VHA facilities. The prime contractor is Vyne Pharmaceuticals Inc., doing business as Menlo Therapeutics, with a potential value of $225,000 over the period of performance from August 2020 through August 2022. The contract was...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Valinor Pharma, LLC, a for-profit limited liability company. The contract is a multiple award, non-set-aside agreement with a ceiling value of $25,000.00 and a period of performance through October 17, 2023. The contract is an "Interim Agreement" issued under Federal Supply Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related...
The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
The Federal Supply Schedule (FSS) contract 36F79718D0514 was awarded by the Department of Veterans Affairs (VA) to Alkermes, Inc. for the provision of pharmaceutical and hematology-related products. This multiple-award contract falls under the GSA Schedule 61-IB for Pharmaceuticals and Drugs, with a period of performance extending to July 31, 2025 and a total ceiling value of $186,349,650.00. The contract aims to procure a wide range of pharmaceutical and hematology products to support the...